How do I interpret my genomic profiling results for Prostate Cancer

Understanding Your Genomic Profiling Results for Prostate Cancer

Genomic profiling is a powerful tool that analyzes the genetic mutations in your cancer cells. Let me walk you through how to interpret these results and what they mean for your treatment options.

What Genomic Profiling Does

Genomic profiling examines the DNA of your cancer cells to identify specific mutations—essentially looking for "broken" genes that may be driving your cancer growth. This information helps your oncologist understand:

• Which mutations are present in your tumor
• What treatment options those mutations may respond to
• Whether you're eligible for clinical trials targeting specific mutations

Common Mutations Found in Advanced Prostate Cancer

Here are mutations frequently identified in prostate cancer genomic testing:

DNA Repair Gene Mutations (BRCA1, BRCA2, ATM, CHEK2, etc.)

These mutations affect your cancer cells' ability to repair damaged DNA. According to the CancerPatientLab webinar on advanced prostate cancer, PARP inhibitors (drugs that block DNA repair) can be particularly effective against cancers with these mutations. PARP inhibitors work by preventing cancer cells from fixing their DNA damage, causing the cells to die.

Androgen Receptor (AR) Mutations

The androgen receptor controls how cancer cells respond to testosterone. Mutations here may indicate:

• Potential resistance to hormone therapies
• Possible benefit from newer AR-targeted drugs
• Consideration of alternative approaches like bipolar androgen therapy (BAT)

PTEN, TP53, or Other Tumor Suppressor Mutations

Loss of these "brake pedal" genes may suggest:

• More aggressive cancer behavior
• Potential eligibility for immunotherapy trials
• Need for combination treatment approaches

Mismatch Repair Gene Defects (MLH1, MSH2, MSH6, PMS2)

These mutations may indicate:

• Potential benefit from immunotherapy
• Higher mutation burden in the cancer
• Possible eligibility for checkpoint inhibitor trials

How to Read Your Report

Your genomic report should include:

1. Mutation Name - The specific gene affected
2. Variant Type - Whether it's a deletion, insertion, or other change
3. Pathogenicity - Whether it's "pathogenic" (harmful) or "likely pathogenic"
4. Therapeutic Implications - What treatments this mutation may respond to

What This Means for Treatment

According to Dr. [removed] Subudhi's webinar on immunotherapies for metastatic castration-resistant prostate cancer, the field is moving toward precision oncology—matching specific mutations to targeted treatments. Current approaches include:

• PARP inhibitors for DNA repair mutations
• Hormone-targeted therapies for AR mutations
• Immunotherapies (checkpoint inhibitors, CAR-T cells, T-cell bispecifics) for certain mutation profiles
• Clinical trials testing combination approaches

The webinar on bipolar androgen therapy notes that genomic results help determine whether cycling testosterone levels (BAT) might be beneficial, particularly when combined with other therapies.

Important Questions to Ask Your Oncologist

Since genomic profiling is complex and personalized to YOUR specific cancer, here are critical questions:

1. "Which mutations in my report are most clinically significant for my treatment?"
2. "Are there FDA-approved drugs that target my specific mutations?"
3. "Am I eligible for any clinical trials based on my genomic results?"
4. "How do these results change my treatment plan compared to standard therapy?"
5. "Should we repeat genomic testing if my cancer progresses on current treatment?"

Important Considerations

• Genomic results are one piece of the puzzle - Your doctor will also consider your PSA levels, imaging scans, clinical symptoms, and overall health
• Liquid biopsies (blood tests) can sometimes provide additional genomic information over time
• Results may evolve - If your cancer progresses, repeat testing may reveal new mutations
• Not all mutations have known treatments yet - Some findings are still being researched in clinical trials

Next Steps

If you've received genomic profiling results:

1. Request a detailed explanation from your oncologist
2. Ask specifically which mutations have treatment implications
3. Inquire about clinical trials matching your mutation profile
4. Consider getting a second opinion from a genitourinary (GU) medical oncologist specializing in prostate cancer

According to the CancerPatientLab webinars, having a specialized prostate cancer oncologist review your genomic results is particularly valuable, as they understand the latest treatment options and trial opportunities for your specific mutations.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.